Published in J Biol Chem on August 28, 2001
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother (2010) 2.41
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev (2003) 1.91
Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues. Antimicrob Agents Chemother (2002) 1.79
Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog (2013) 1.75
A novel mechanism of selectivity against AZT by the human mitochondrial DNA polymerase. Nucleic Acids Res (2007) 1.44
Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS (2006) 1.43
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med (2008) 1.37
Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent. Antimicrob Agents Chemother (2002) 1.28
Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase. Antimicrob Agents Chemother (2004) 1.27
3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity. Biochem Pharmacol (2006) 1.25
The DNA polymerase gamma Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine. Hum Mol Genet (2007) 1.19
Importance of hydrogen bonding for efficiency and specificity of the human mitochondrial DNA polymerase. J Biol Chem (2007) 1.19
Role of purine nucleoside phosphorylase in interactions between 2',3'-dideoxyinosine and allopurinol, ganciclovir, or tenofovir. Antimicrob Agents Chemother (2004) 1.13
Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication. J Biol Chem (2009) 1.11
Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. Cardiovasc Toxicol (2004) 1.11
Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol (2010) 1.10
Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis (2008) 1.10
TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res (2013) 1.08
Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals. Fertil Steril (2011) 1.08
Current perspectives on HIV-1 antiretroviral drug resistance. Viruses (2014) 1.04
A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis. Nucleic Acids Res (2001) 1.02
The mitochondrial DNA polymerase in health and disease. Subcell Biochem (2010) 0.98
Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity. Antimicrob Agents Chemother (2004) 0.98
Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana. BMC Infect Dis (2013) 0.98
R964C mutation of DNA polymerase gamma imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. Antimicrob Agents Chemother (2009) 0.98
Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition. Antimicrob Agents Chemother (2007) 0.97
Aging and HIV/AIDS: pathogenetic role of therapeutic side effects. Lab Invest (2013) 0.95
Antiretroviral therapy in the clinic. J Virol (2010) 0.95
Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. Antimicrob Agents Chemother (2007) 0.95
Clinical features of adverse reactions associated with telbivudine. World J Gastroenterol (2008) 0.95
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug. Antimicrob Agents Chemother (2014) 0.94
Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase. J Biol Chem (2008) 0.94
Nucleotide incorporation by human DNA polymerase gamma opposite benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyguanosine and deoxyadenosine. Nucleic Acids Res (2004) 0.93
Human mitochondrial RNA polymerase: evaluation of the single-nucleotide-addition cycle on synthetic RNA/DNA scaffolds. Biochemistry (2011) 0.92
Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicity. Antimicrob Agents Chemother (2011) 0.91
Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog. Antimicrob Agents Chemother (2007) 0.91
Role of histidine 932 of the human mitochondrial DNA polymerase in nucleotide discrimination and inherited disease. J Biol Chem (2010) 0.90
Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases. Antimicrob Agents Chemother (2010) 0.89
Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction. Cardiovasc Toxicol (2008) 0.89
Effect of the Y955C mutation on mitochondrial DNA polymerase nucleotide incorporation efficiency and fidelity. Biochemistry (2011) 0.89
Zidovudine and Lamivudine for HIV Infection. Clin Med Rev Ther (2010) 0.89
Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase. Mol Pharmacol (2012) 0.88
A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease. Biochim Biophys Acta (2010) 0.88
Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors. Am J Hum Genet (2003) 0.88
Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides. Cell Cycle (2016) 0.88
High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers. Antimicrob Agents Chemother (2008) 0.87
Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity. J Biol Chem (2016) 0.84
Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolites. Antimicrob Agents Chemother (2010) 0.84
Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) using pre-steady-state kinetics. Antiviral Res (2014) 0.84
An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors. PLoS Comput Biol (2009) 0.83
HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection. PLoS Comput Biol (2012) 0.83
Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract. Antiviral Res (2012) 0.83
Toxicity and tolerance mechanisms for azidothymidine, a replication gap-promoting agent, in Escherichia coli. DNA Repair (Amst) (2010) 0.83
Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus. Antimicrob Agents Chemother (2015) 0.83
Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon. AIDS Res Ther (2014) 0.82
Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase. EMBO J (2015) 0.82
Impact of age on markers of HIV-1 disease. Future Virol (2013) 0.82
Cytokine and sex hormone effects on zidovudine- and lamivudine-triphosphate concentrations in vitro. J Antimicrob Chemother (2008) 0.82
Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases. Chem Res Toxicol (2011) 0.81
Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile. Antimicrob Agents Chemother (2009) 0.80
Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy. Chem Res Toxicol (2008) 0.80
Retention of metabolites of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells. Antimicrob Agents Chemother (2009) 0.79
Application of artificial neural network to investigate the effects of 5-fluorouracil on ribonucleotides and deoxyribonucleotides in HepG2 cells. Sci Rep (2015) 0.79
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine. Antimicrob Agents Chemother (2012) 0.79
Abacavir/lamivudine combination in the treatment of HIV: a review. Ther Clin Risk Manag (2010) 0.79
Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk. Antimicrob Agents Chemother (2016) 0.78
Exonuclease removal of dideoxycytidine (zalcitabine) by the human mitochondrial DNA polymerase. Antimicrob Agents Chemother (2007) 0.78
BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue. Antimicrob Agents Chemother (2013) 0.78
Short-interference RNAs: becoming medicines. EXCLI J (2015) 0.78
DNA polymerase γ and disease: what we have learned from yeast. Front Genet (2015) 0.78
Kinetic characterization of exonuclease-deficient Staphylococcus aureus PolC, a C-family replicative DNA polymerase. PLoS One (2013) 0.78
A computational model of mitochondrial AZT metabolism. Biochem J (2005) 0.77
Analysis of enzyme kinetic data for mtDNA replication. Methods (2010) 0.77
Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion. CMAJ (2003) 0.77
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae. Mitochondrion (2014) 0.77
Relaxation effect of abacavir on rat basilar arteries. PLoS One (2015) 0.77
Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity. PLoS One (2015) 0.77
Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol. Antimicrob Agents Chemother (2015) 0.77
A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma. Methods (2010) 0.77
Connecting Replication and Repair: YoaA, a Helicase-Related Protein, Promotes Azidothymidine Tolerance through Association with Chi, an Accessory Clamp Loader Protein. PLoS Genet (2015) 0.76
Drug-induced Liver Injury. US Gastroenterol Hepatol Rev (2010) 0.76
Structural basis for the binding and incorporation of nucleotide analogs with L-stereochemistry by human DNA polymerase λ. Proc Natl Acad Sci U S A (2014) 0.75
Zidovudine induces downregulation of mitochondrial deoxynucleoside kinases: implications for mitochondrial toxicity of antiviral nucleoside analogs. Antimicrob Agents Chemother (2014) 0.75
Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors. Drug Discov Today Technol (2012) 0.75
Mitochondrial DNA replication: a PrimPol perspective. Biochem Soc Trans (2017) 0.75
Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine. Toxicol In Vitro (2016) 0.75
Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosine. Antimicrob Agents Chemother (2005) 0.75
Structural basis for the D-stereoselectivity of human DNA polymerase β. Nucleic Acids Res (2017) 0.75
A motility in the eukaryotic flagellum unrelated to flagellar beating. Proc Natl Acad Sci U S A (1993) 6.50
Negative feedback defining a circadian clock: autoregulation of the clock gene frequency. Science (1994) 5.76
Birth outcomes in pregnant women taking fluoxetine. N Engl J Med (1996) 5.38
Purification of tubulin and associated high molecular weight proteins from porcine brain and characterization of microtubule assembly in vitro. Ann N Y Acad Sci (1975) 5.26
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem (1992) 4.57
Pre-steady-state kinetic analysis of processive DNA replication including complete characterization of an exonuclease-deficient mutant. Biochemistry (1991) 4.55
Construction and evaluation of the kinetic scheme associated with dihydrofolate reductase from Escherichia coli. Biochemistry (1987) 4.29
In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc Natl Acad Sci U S A (2001) 3.97
Kinetic mechanism of DNA polymerase I (Klenow). Biochemistry (1987) 3.93
An induced-fit kinetic mechanism for DNA replication fidelity: direct measurement by single-turnover kinetics. Biochemistry (1991) 3.86
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science (1995) 3.60
Pathway of processive ATP hydrolysis by kinesin. Nature (1995) 3.46
Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry (1996) 3.36
Large porous particles for pulmonary drug delivery. Science (1997) 3.35
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Circadian clock locus frequency: protein encoded by a single open reading frame defines period length and temperature compensation. Proc Natl Acad Sci U S A (1994) 3.23
Kinetic analysis of microtubule self-assembly in vitro. J Mol Biol (1977) 3.15
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med (1992) 2.39
Role of tubulin-associated proteins in microtubule nucleation and elongation. J Mol Biol (1977) 2.38
Intermediate states of subfragment 1 and actosubfragment 1 ATPase: reevaluation of the mechanism. Biochemistry (1978) 2.35
Microtuble assembly: some possible regulatory mechanisms. J Supramol Struct (1974) 2.21
Pathway of the microtubule-dynein ATPase and the structure of dynein: a comparison with actomyosin. Annu Rev Biophys Biophys Chem (1985) 2.17
Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A (1993) 2.16
Association between wild type and mutant APC gene products. Cancer Res (1993) 2.08
Expression, purification, and characterization of the Drosophila kinesin motor domain produced in Escherichia coli. Biochemistry (1993) 2.06
rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1988) 2.06
Structure and molecular weight of the dynein ATPase. J Cell Biol (1983) 2.01
Pathway of ATP hydrolysis by monomeric and dimeric kinesin. Biochemistry (1998) 2.01
Impingement of the lesser trochanter on the ischial ramus after total hip arthroplasty. Report of three cases. J Bone Joint Surg Am (1977) 1.97
Alternating site mechanism of the kinesin ATPase. Biochemistry (1998) 1.90
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science (1999) 1.88
Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol (2015) 1.86
Expression of the APC tumor suppressor protein in oligodendroglia. Glia (1996) 1.77
Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci U S A (1990) 1.74
Elementary steps in the DNA polymerase I reaction pathway. Biochemistry (1983) 1.73
The crystal structure of polygalacturonase-inhibiting protein (PGIP), a leucine-rich repeat protein involved in plant defense. Proc Natl Acad Sci U S A (2003) 1.72
Rapid kinetic analysis of mechanochemical adenosinetriphosphatases. Methods Enzymol (1986) 1.72
H. M.'s medial temporal lobe lesion: findings from magnetic resonance imaging. J Neurosci (1997) 1.71
Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology (1995) 1.71
Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol (1986) 1.70
Decoration of the microtubule surface by one kinesin head per tubulin heterodimer. Nature (1993) 1.69
Dynamics of ribozyme binding of substrate revealed by fluorescence-detected stopped-flow methods. Science (1992) 1.69
Sulfur transfer from IscS to IscU: the first step in iron-sulfur cluster biosynthesis. J Am Chem Soc (2001) 1.68
Characterization of the ATP-sensitive binding of Tetrahymena 30 S dynein to bovine brain microtubules. J Biol Chem (1983) 1.67
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat (1999) 1.63
Human mitochondrial DNA polymerase holoenzyme: reconstitution and characterization. Biochemistry (2000) 1.62
Exonuclease proofreading by human mitochondrial DNA polymerase. J Biol Chem (2001) 1.60
Rescue of a paralyzed-flagella mutant of Chlamydomonas by transformation. Proc Natl Acad Sci U S A (1990) 1.60
Kinetic partitioning between the exonuclease and polymerase sites in DNA error correction. Biochemistry (1991) 1.60
A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci (1997) 1.58
Pre-steady-state kinetics of the microtubule-kinesin ATPase. Biochemistry (1994) 1.56
Large scale purification and biochemical characterization of T7 primase/helicase proteins. Evidence for homodimer and heterodimer formation. J Biol Chem (1992) 1.52
Musculoskeletal and soft tissue Aeromonas infection: an environmental disease. Mayo Clin Proc (1992) 1.52
A family of major royal jelly proteins of the honeybee Apis mellifera L. Cell Mol Life Sci (1998) 1.52
Error-prone replication of repeated DNA sequences by T7 DNA polymerase in the absence of its processivity subunit. Proc Natl Acad Sci U S A (1994) 1.51
Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res (1996) 1.49
Fidelity of nucleotide incorporation by human mitochondrial DNA polymerase. J Biol Chem (2001) 1.47
Rate-limiting steps in the DNA polymerase I reaction pathway. Biochemistry (1985) 1.46
Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase. Biochemistry (1999) 1.45
The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: a dynamic force monitoring study. Foot Ankle (1992) 1.44
Isolated talocalcaneal arthrodesis. A technique using moldable bone graft. J Bone Joint Surg Am (1988) 1.44
Circadian rhythms. Brain Res Brain Res Rev (1993) 1.43
Colles' fracture and subsequent hip fracture risk. Clin Orthop Relat Res (1983) 1.43
Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. Oncogene (2007) 1.42
Antigen recognition by conformational selection. FEBS Lett (1999) 1.42
A hexameric helicase encircles one DNA strand and excludes the other during DNA unwinding. Biochemistry (1997) 1.40
Outcome of femoral head ostectomy in dogs and cats. Munich publication reprinted. Vet Comp Orthop Traumatol (2010) 1.39
Expression, purification, and initial kinetic characterization of the large subunit of the human mitochondrial DNA polymerase. Biochemistry (1998) 1.39
"What's a foot surgeon to believe?". Foot Ankle (1993) 1.39
A relational database for diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry. Am J Clin Pathol (2000) 1.38
Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol (2006) 1.32
Activation of the dynein adenosinetriphosphatase by microtubules. Biochemistry (1986) 1.32
Presteady state kinetic analysis of vanadate-induced inhibition of the dynein ATPase. J Biol Chem (1983) 1.31
Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone (1994) 1.31
Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem (2001) 1.31
Sedimentation studies on the kinesin motor domain constructs K401, K366, and K341. Biochemistry (1995) 1.31
The results of anterior interbody fusion of the cervical spine. Review of ninety-three consecutive cases. J Neurosurg (1969) 1.31
Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res (1992) 1.30
Identification of a molecular chaperone in the eukaryotic flagellum and its localization to the site of microtubule assembly. J Cell Sci (1995) 1.30
Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase. Biochemistry (1999) 1.30
Structure and topological symmetry of the glyphosate target 5-enolpyruvylshikimate-3-phosphate synthase: a distinctive protein fold. Proc Natl Acad Sci U S A (1991) 1.29
Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci U S A (1996) 1.28
Radiographic measurements of the normal adult foot. Foot Ankle (1980) 1.27
Microtubules accelerate ADP release by dynein. Biochemistry (1989) 1.27
Y265H mutator mutant of DNA polymerase beta. Proper teometric alignment is critical for fidelity. J Biol Chem (2001) 1.27
Effects of biological source on cooking and palatability attributes of beef produced for the Japanese market. Meat Sci (1993) 1.27
Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. J Biol Chem (1988) 1.27
Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci U S A (2001) 1.26
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Hepatology (1998) 1.26
Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA (1980) 1.25
Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase. Biochemistry (1997) 1.25